Vanguard Group Inc Novavax Inc Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
290Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Black Rock Inc. New York, NY11.8MShares$103 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$85.4 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$66.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$51.7 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA3.5MShares$30.5 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $680M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...